1) stageⅡandⅢbreast cancers
Ⅱ、Ⅲ期乳腺癌
1.
Objective: To evaluate the effect of the three radiotherapy methods by comparing the incidence of radioactive dermatitis, the occurrence of radiation-induced lung injury, local recurrence rate, distant metastasis rate in receiving radiotherapy on the chest wall and supraclavicular area of the postoperative stageⅡandⅢbreast cancers.
目的:通过对Ⅱ、Ⅲ期乳腺癌根治或改良根治术后胸壁、锁骨上区放射治疗后放射性皮肤反应情况、放射性肺损伤发生率、胸壁复发率、远处转移率的比较,评价三种放射治疗方法的疗效。
2) stage Ⅱ and Ⅲ breast cancer
乳腺癌Ⅱ期及Ⅲ期
3) Ⅲ Stage breast cancer
Ⅲ期乳腺癌
1.
Clinical study on Ⅲ Stage breast cancer patients treated by neoadjuvant chemotherapy;
新辅助化疗对80例Ⅲ期乳腺癌患者5年生存率的回顾性分析
5) Early-stage breast cancer
早期乳腺癌
1.
Herceptin plus adjuvant chemotherahy for the prognosis of patients with human epithelial growth factor receptor 2 positive early-stage breast cancer: a Meta-analysis;
赫赛汀联合辅助化疗对人类表皮生长因子受体2阳性早期乳腺癌患者预后影响的Meta分析
2.
Clinical analysis of breast conserving surgery for early-stage breast cancer in 35 cases;
早期乳腺癌保乳手术35例临床分析
3.
Objective To evaluate the effects of Trastuzumab on the prognosis of HER2 positive patients with early-stage breast cancer by meta-analysis.
目的应用Meta分析的方法探讨曲妥珠单抗对HER2阳性早期乳腺癌患者预后的影响。
6) Advanced breast cancer
晚期乳腺癌
1.
Clinical observation of docetaxel with DDP treating advanced breast cancer;
多烯紫杉醇联合顺铂治疗晚期乳腺癌疗效观察
2.
The comparison of TP and NP regimens in the treatment of advanced breast cancer;
TP与NP方案治疗晚期乳腺癌的临床观察
3.
Clinical observation on docetaxel combined with xeloda in treatment of advanced breast cancer;
希罗达联合艾素治疗晚期乳腺癌的临床观察
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条